What is the treatment for Candida glabrata in urine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Candida Glabrata in Urine

For fluconazole-resistant Candida glabrata in urine, amphotericin B deoxycholate at 0.3-0.6 mg/kg daily for 1-7 days OR oral flucytosine at 25 mg/kg 4 times daily for 7-10 days is recommended as first-line treatment. 1

Assessment and Initial Management

Before initiating treatment, consider these important factors:

  1. Determine if treatment is necessary:

    • Treatment is NOT recommended for asymptomatic candiduria unless the patient belongs to a high-risk group 1, 2
    • High-risk groups requiring treatment include:
      • Neutropenic patients
      • Very low birth weight infants (<1500g)
      • Patients undergoing urologic manipulation
      • Patients with suspected disseminated infection
  2. Remove predisposing factors:

    • Elimination of indwelling bladder catheters is strongly recommended whenever feasible 1
    • Removing catheters alone can resolve candiduria in approximately 50% of cases 2
  3. Identify the organism and susceptibility:

    • Obtain urine culture to confirm Candida glabrata and determine antifungal susceptibility 2

Treatment Algorithm for Candida Glabrata UTI

For Symptomatic Cystitis:

  1. First-line options (C. glabrata is typically fluconazole-resistant):

    • Amphotericin B deoxycholate: 0.3-0.6 mg/kg daily for 1-7 days 1
    • Oral flucytosine: 25 mg/kg 4 times daily for 7-10 days 1
  2. Alternative/adjunctive options:

    • Amphotericin B deoxycholate bladder irrigation: 50 mg/L sterile water daily for 5 days 1
    • In transplant recipients with chronic symptomatic infection, micafungin 100-150 mg daily may be considered despite poor urinary concentrations 2, 3

For Pyelonephritis:

  1. First-line options:

    • Amphotericin B deoxycholate: 0.3-0.6 mg/kg daily for 1-7 days with or without oral flucytosine 1
    • Oral flucytosine monotherapy: 25 mg/kg 4 times daily for 2 weeks (consider in select cases) 1
  2. Additional measures:

    • Eliminate urinary tract obstruction (strongly recommended) 1
    • Remove or replace nephrostomy tubes/stents if present 1
    • Consider irrigation through nephrostomy tubes with amphotericin B deoxycholate (25-50 mg in 200-500 mL sterile water) 1

For Fungal Balls or Abscesses:

  • Surgical intervention is strongly recommended 1
  • Combine with appropriate antifungal therapy as noted above 1, 2

Special Considerations

  1. Duration of therapy:

    • Typically 2 weeks for uncomplicated infections 1, 2
    • Continue until symptoms resolve and urine cultures become negative 2
  2. Monitoring:

    • Follow-up urine cultures to confirm eradication 2
    • Monitor renal function, especially with amphotericin B due to nephrotoxicity risk 2
  3. Cautions:

    • Newer azoles and echinocandins generally achieve poor urine concentrations and are not recommended for uncomplicated urinary tract infections 4
    • However, echinocandins may be considered when infection has invaded renal tissue rather than being limited to the collecting system 2, 5
  4. For patients undergoing urologic procedures:

    • Prophylactic treatment with oral fluconazole 400 mg daily OR amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure 1

Pitfalls to Avoid

  1. Treating asymptomatic candiduria in patients without risk factors for dissemination - this is not recommended and may lead to unnecessary drug exposure and resistance 1, 2

  2. Relying on echinocandins as first-line therapy for uncomplicated urinary tract infections due to their poor urinary concentrations 4

  3. Failing to remove urinary catheters when feasible - catheter removal alone resolves many cases without antifungal therapy 1, 2

  4. Overlooking the need for surgical intervention in cases with fungal balls or abscesses 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antifungal Therapy in Transplant Recipients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of candiduria with micafungin: A case series.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2007

Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.